SCHEMBL5262953

SCHEMBL5262953

COc1cc2nc(-c3ccc(C)cc3)nc(Cl)c2cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WHR1 P49842 1/20 0.54
▸ PDGFRB P09619 2/20 0.51
▸ PDGFRA P16234 2/20 0.51
▸ DHPS P49366 2/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ STAT6 P42226 1/20 0.46
▸ SLC2A1 P11166 2/20 0.45
▸ MAPT P10636 3/20 0.44
▸ TP53 P04637 3/20 0.44
▸ NTSR1 P30989 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ NPC1 O15118 1/20 0.40
▸ XBP1 P17861 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ ENPP1 P22413 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MITF O75030 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5258591 0.90 WHR1 (0.55) WHR1PDGFRBPDGFRADHPSNPSR1
SCHEMBL10063506 0.87 WHR1 (0.52) WHR1PDGFRBPDGFRADHPSNPSR1
SCHEMBL3976324 0.87 SLC2A1 (0.56) WHR1PDGFRBPDGFRADHPSNPSR1
SCHEMBL16384708 0.87 WHR1 (0.52) WHR1PDGFRBPDGFRADHPSNPSR1
SCHEMBL29589069 0.87 WHR1 (0.71) WHR1PDGFRBPDGFRADHPSNPSR1
SCHEMBL20771102 0.87 WHR1 (0.71) WHR1PDGFRBPDGFRADHPSNPSR1
SCHEMBL29589358 0.85 WHR1 (0.54) WHR1PDGFRBPDGFRANPSR1KDM4E
SCHEMBL3469022 0.85 WHR1 (0.54) WHR1PDGFRBPDGFRANPSR1KDM4E
SCHEMBL5261050 0.83 WHR1 (0.49) WHR1PDGFRBPDGFRANPSR1KDM4E
SCHEMBL5257184 0.82 WHR1 (0.54) WHR1PDGFRBPDGFRANPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040101-B1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-04-25 — — EP disclosed
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 — — US disclosed
EP-1040101-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2000-10-04 — — EP disclosed
WO-1999032460-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-01 — — WO disclosed
Send feedback